Opdualag 00003-7125-11
Generic: Nivolumab And Relatlimab-Rmbw
- Manufacturer
- E.r. Squibb & Sons, L.l.c.
- Dosage Form
- Injection
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- March 18, 2022
- Listing Expires
- December 31, 2026
- Application
- BLA761234
Need to source Opdualag? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Nivolumab | 12 mg/mL |
| Relatlimab | 4 mg/mL |
Drug Class
Programmed Death Receptor-1 Blocking Antibody [EPC]Lymphocyte Activation Gene-3 Blocker [EPC]Lymphocyte Activation Gene-3 Antagonists [MoA]
Selected Package
00003-7125-11Selected1 VIAL, SINGLE-DOSE in 1 CARTON (0003-7125-11) / 20 mL in 1 VIAL, SINGLE-DOSE